Opportunities for an atherosclerosis vaccine: From mice to humans.

Roy, Payel; Ali, Amal J; Kobiyama, Kouji; Ghosheh, Yanal; Ley, Klaus

Roy, Payel; Ali, Amal J; Kobiyama, Kouji; Ghosheh, Yanal; Ley, Klaus.

Afiliação

Roy P; Division of Inflammation Biology, La Jolla Institute for Immunology, 9420, Athena Circle Drive, La Jolla, CA 92037, USA.
Ali AJ; Division of Inflammation Biology, La Jolla Institute for Immunology, 9420, Athena Circle Drive, La Jolla, CA 92037, USA.
Kobiyama K; Division of Inflammation Biology, La Jolla Institute for Immunology, 9420, Athena Circle Drive, La Jolla, CA 92037, USA; Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Ghosheh Y; Division of Inflammation Biology, La Jolla Institute for Immunology, 9420, Athena Circle Drive, La Jolla, CA 92037, USA.
Ley K; Division of Inflammation Biology, La Jolla Institute for Immunology, 9420, Athena Circle Drive, La Jolla, CA 92037, USA; Department of Bioengineering, University of California San Diego, 9500 Gilman Drive, MC0412, La Jolla, CA 92093, USA. Electronic address: klaus@lji.org.

Vaccine ; 38(28): 4495-4506, 2020 06 09.

Article em En | MEDLINE | ID: mdl-31964554

Assuntos

Aterosclerose; Vacinas; Imunidade Adaptativa; Animais; Aterosclerose/prevenção & controle; Humanos; Inflamação; Camundongos; Vacinação

Palavras-chave

Antigen-specific; Atherosclerosis; Immunomodulation; Peptide-based vaccine; Tregs

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Aterosclerose Limite: Animals / Humans Idioma: En Revista: Vaccine Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google